65219-95-6

Upstream product

• 36277-32-4 ethyl 3-morpholinobut-2-enoate 
• 1181458-21-8 (4-Bromo-2-methoxy-6-methyl-phenyl)-amine hydrobromide 
• 877149-05-8 4-bromo-2-methoxy-6-methyl-benzonitrile 
• 1244949-43-6 4-bromo-2-methoxy-6-methyl-benzaldehyde 
• 877149-08-1 4-bromo-2-methoxy-6-methyl-benzoic acid 
• 1472104-38-3 4-bromo-2-methoxy-6-methyl-benzoic acid ethyl ester 
• 1472104-39-4 2-methoxy-6-methyl-4-morpholin-4-yl-benzoic acid ethyl ester 
• 50868-73-0 2-methoxy-6-methylbenzeneamine 

Downstream Products

• 1472104-41-8 2-cyclopropyl-6-methyl-4-morpholin-4-yl-benzoic acid ethyl ester 
• 1472104-42-9 2-cyclopropyl-6-methyl-4-morpholin-4-yl-benzoic acid 
• 1472103-93-7 2-cyclopropyl-N-[(3R)-3-hydroxy-4,4-dimethyl-pentyl]-6-methyl-4-morpholin-4-yl-benzamide 
• 1472104-40-7 2-methyl-4-morpholin-4-yl-6-(trifluoromethylsulfonyl)oxy-benzoic acid ethyl ester 

Relevant academic research and scientific papers

SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS

The invention relates to substituted 4-aminobenzamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

SUBSTITUTED 4-AMINOBENZAMIDES AS KCNQ2/3 MODULATORS

Substituted 4-aminobenzamides, pharmaceutical compositions containing these compounds and also methods of using these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.